| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abolition of Prescription Copayments in Wales: An Observational Study on Dispensing Rates
|
Cohen, David
|
|
2010
|
13 |
5 |
p. 675-680
6 p.
|
artikel
|
| 2 |
A Cost-Utility Analysis of Microwave Endometrial Ablation versus Thermal Balloon Endometrial Ablation
|
Kilonzo, Mary M.
|
|
2010
|
13 |
5 |
p. 528-534
7 p.
|
artikel
|
| 3 |
A Portuguese Value Set for the SF-6D
|
Ferreira, Lara N.
|
|
2010
|
13 |
5 |
p. 624-630
7 p.
|
artikel
|
| 4 |
A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group
|
Guo, Jeff J.
|
|
2010
|
13 |
5 |
p. 657-666
10 p.
|
artikel
|
| 5 |
Assessing the Economic Value of Public Health Programs Based on Risk: The Case of the Cancer Plan in France
|
Guerrero, Isabelle
|
|
2010
|
13 |
5 |
p. 552-556
5 p.
|
artikel
|
| 6 |
A Valuation of Infusion Therapy to Preserve Islet Function in Type 1 Diabetes
|
Lloyd, Andrew
|
|
2010
|
13 |
5 |
p. 636-642
7 p.
|
artikel
|
| 7 |
Consequences of Screening in Lung Cancer: Development and Dimensionality of a Questionnaire
|
Brodersen, John
|
|
2010
|
13 |
5 |
p. 601-612
12 p.
|
artikel
|
| 8 |
Constructing a Conceptual Framework of Patient-Reported Outcomes for Metastatic Hormone-Refractory Prostate Cancer
|
Eton, David T.
|
|
2010
|
13 |
5 |
p. 613-623
11 p.
|
artikel
|
| 9 |
Cost-Effectiveness of Duloxetine: The Stress Urinary Incontinence Treatment (SUIT) Study
|
Mihaylova, Borislava
|
|
2010
|
13 |
5 |
p. 565-572
8 p.
|
artikel
|
| 10 |
Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis
|
Wu, Bin
|
|
2010
|
13 |
5 |
p. 592-600
9 p.
|
artikel
|
| 11 |
Cost–Utility Analysis of Topical Intranasal Steroids for Otitis Media with Effusion Based on Evidence from the GNOME Trial
|
Petrou, Stavros
|
|
2010
|
13 |
5 |
p. 543-551
9 p.
|
artikel
|
| 12 |
Early-Stage Valuation of Medical Devices: The Role of Developmental Uncertainty
|
Girling, Alan
|
|
2010
|
13 |
5 |
p. 585-591
7 p.
|
artikel
|
| 13 |
Eliciting Distributions to Populate Decision Analytic Models
|
Bojke, Laura
|
|
2010
|
13 |
5 |
p. 557-564
8 p.
|
artikel
|
| 14 |
Empirically Evaluating Decision-Analytic Models
|
Goldhaber-Fiebert, Jeremy D.
|
|
2010
|
13 |
5 |
p. 667-674
8 p.
|
artikel
|
| 15 |
Evaluating Interventions to Improve Antiretroviral Adherence: How Much of an Effect Is Required for Favorable Value?
|
Braithwaite, R. Scott
|
|
2010
|
13 |
5 |
p. 535-542
8 p.
|
artikel
|
| 16 |
General Population Reference Values for the French Version of the EuroQol EQ-5D Health Utility Instrument
|
Perneger, Thomas V.
|
|
2010
|
13 |
5 |
p. 631-635
5 p.
|
artikel
|
| 17 |
Incorporating Equity–Efficiency Interactions in Cost-Effectiveness Analysis—Three Approaches Applied to Breast Cancer Control
|
Baeten, Stefan A.
|
|
2010
|
13 |
5 |
p. 573-579
7 p.
|
artikel
|
| 18 |
Network Meta-Analysis: Importance of Appropriate Trial Selection
|
Edwards, Steven J.
|
|
2010
|
13 |
5 |
p. 681-682
2 p.
|
artikel
|
| 19 |
Populating an Economic Model with Health State Utility Values: Moving toward Better Practice
|
Ara, Roberta
|
|
2010
|
13 |
5 |
p. 509-518
10 p.
|
artikel
|
| 20 |
Projecting the Effect of Nesiritide on Dialysis and Hospital Mortality in Cardiac Surgery Patients
|
He, Jinghua
|
|
2010
|
13 |
5 |
p. 643-648
6 p.
|
artikel
|
| 21 |
Response to Comments on “No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data”
|
Hawkins, Neil
|
|
2010
|
13 |
5 |
p. 683-
1 p.
|
artikel
|
| 22 |
Small Budget Impact Is a Result of Flawed Assumptions and Ignores Questionable Cost-Effectiveness for RSV Prophylaxis
|
Hampp, Christian
|
|
2010
|
13 |
5 |
p. 684-
1 p.
|
artikel
|
| 23 |
The Cost-Effectiveness of Group Cognitive Behavioral Therapy Compared with Routine Primary Care for Women with Postnatal Depression in the UK
|
Stevenson, Matt D.
|
|
2010
|
13 |
5 |
p. 580-584
5 p.
|
artikel
|
| 24 |
The Transferability of Valuing Lost Productivity across Jurisdictions. Differences between National Pharmacoeconomic Guidelines
|
Knies, Saskia
|
|
2010
|
13 |
5 |
p. 519-527
9 p.
|
artikel
|
| 25 |
Validation and Comparison of EuroQol and Short Form 6D in Chronic Prostatitis Patients
|
Zhao, Fei-li
|
|
2010
|
13 |
5 |
p. 649-656
8 p.
|
artikel
|
Tijdschrift beschrijving